Thomas J. Schall, President and CEO at ChemoCentryx, Inc. (CCXI), sold 73,524 shares at $12.16 ($894K) on 2019-01-10, disclosed to the SEC on 2019-01-14.
Open-market sale of $894k CCXI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.16 | 36,762 | $447K | 50.0% |
| 2 | $12.16 | 36,762 | $447K | 50.0% |
| Total | $12.16 avg | 73,524 | $894K | 100% |
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| IMRX | BUY | 2024-03-25 | $7K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |